3gen manufactures the DermLite brand of skin imaging devices www.dermlite.com
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. www.abbvie.com
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. www.aclaristx.com
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. For more information, visit Allergan’s website at www.Allergan.com
Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera's primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer.
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life changing drugs for our patients. Our mission as a company is to build a major biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of Cancer and other severe, immune, inflammatory conditions. www.celgene.com
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care.
Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in more than 100 countries, with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galdermausa.com and www.galderma.com
Janssen Biotech, Inc., a member of Janssen Pharmaceutical Companies of Johnson & Johnson, delivers on the
promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich
legacy of innovative firsts, Janssen Biotech pursues solutions in immunology, oncology, urology, and nephrology. www.janssenbiotech.com
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels
Merz Aesthetics is a division of Merz North America and offers a wide-ranging portfolio of treatment options including Device (Ultherapy®, CellfinaTM System, DESCRIBE® PFD Patch), Injectables (Xeomin®, Radiesse® Volumizing Filler, Belotero Balance®, Asclera®) and Skincare (NEOCUTIS®, Mederma®) that enables physicians to meet the needs of a broad range of patients and their skin concerns. To learn more about Merz Aesthetics and their Device offerings, please visit www.merzusa.com/aesthetics-otc.
MotherToBaby is the nation's leading authority and most trusted source of evidence-based information on the safety of medications and other exposures during pregnancy and while breastfeeding. MotherToBaby Pregnancy Studies is evaluating the effects of Psoriasis and Psoriatic Arthritis along with the medications used to treat these diseases during pregnancy.
Novartis Pharmaceuticals is dedicated to discovering, developing, manufacturing and marketing prescription drugs that help meet our customer's medical needs and improve their quality of life. www.novartis.com
Ortho Dermatologics is committed to the dermatology community and healthcare providers, by helping treat patients in therapeutic areas including acne, immunology and psoriasis. Learn more at www.ortho-dermatologics.com.
From its beginning, Person & Covey, Inc. has worked closely with the medical community to develop high-quality therapeutic formulas, especially in the areas of sun protection and dermatological care. Recognizing that each patient is unique, Person & Covey, Inc. carefully crafts products that are appropriate for use by even the most sensitive of users.
Ra Medical Systems, Inc., markets the Phares Excimer Laser,an advanced 308-nm super narrowband UVB excimer laser for psoriasis, vitiligo, atopic dermatitis, and leukoderma. It is ideal for localized, recalcitrant, and difficult to-treat psoriasis including scalp, palms and soles, and intertriginous lesions and for localized vitiligo, including facial and peri-orbital areas.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. . Our medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.
SPII is a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd, a global specialty generic company based in Mumbai, which provides innovative, high-quality, affordable medicines trusted by customers and patients in over 150 countries around the world. It fosters excellence through innovation, supported by strong R&D capabilities, with approximately 2,000 scientists on staff and R&D investments of approximately 8% of annual revenues. It has been marketing its products in the US market for more than 20 years, providing generics, branded generics and over-the-counter products, and has distribution and customer service teams throughout the US. For further information please visit www.sunpharma.com and follow us on Twitter at @SunPharma_Live